Chemical Communications 2012-12-07

Prussian blue nanoparticles operate as a new generation of photothermal ablation agents for cancer therapy.

Guanglei Fu, Wei Liu, Shanshan Feng, Xiuli Yue

Index: Chem. Commun. (Camb.) 48(94) , 11567-9, (2012)

Full Text: HTML

Abstract

Herein, prussian blue nanoparticles, an ancient dye, were explored as a new generation of near-infrared laser-driven photothermal ablation agents for cancer therapy alternative to traditional agents due to their good photothermal efficiency and high photothermal stability but low cost and particularly clinically approved biosafety.